Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals

NCT06844097 | Not Yet Recruiting

• 2 other identifiers: 2308159535R0012U54CA163071-11
• Study Type: interventional
• Target: 60
• Locations: 0 countries
• Sites: N/A

Brief Summary

The team aims to test the effectiveness of an intervention to increase gender-affirming cervical cancer prevention behaviors targeted at medical students studying in Puerto Rico and Florida. The team expects that after exposure to the intervention, relative to the control group, participants in the experimental condition will manifest more favorable changes in knowledge, attitudes, and behaviors of adequate care towards Latinx transmasculine and non-binary people.

Conditions

Clinical Competence; Medical Education; Cervical Cancer Screening

Keywords

Latinx transmaculine; Latinx Non-Binary; Medical Students; SGM Cancer Research; Efficacy Study; Cervical Cancer Prevention Intervention

Outcome Measures

Primary Outcomes (5)

• Change cervical cancer preventive behaviors, as determined by the Cervical Cancer Preventive Behaviors Inventory

  The CCPBI includes 46 non-verbal and verbal behaviors that can be manifested during the SPS interactions with LTM. The team expects that following intervention exposure, relative to control group participants, intervention participants will manifest a higher mean number of CC preventive behaviors on the CCPBI outcome.

  Baseline, immediately after the intervention

• Change in LTMNB knowledge, as determined by Transmasculine knowledge index

  This measure assesses health professionals' knowledge of TM-specific health issues. Intervention participants, relative to controls, will have a higher mean knowledge (literacy) level regarding LTM issues.

  Baseline, immediately after the intervention

• Change negative attitudes towards LTMNB, as determined by the transgender stigma scale

  This scale measures stigma related to transgender identity among healthcare providers. Intervention participants, relative to controls, will have a lower mean level of stigmatizing attitudes toward LTM

  Baseline, immediately after the intervention

• Change negative and increase positive emotions related to LTMNB, as determined by the Emotional Reactions Scale

  This scale measures emotional reactions to LTMNB. Intervention participants, relative to control participants, will have an increase in the mean of positive emotions, and a reduction in the mean level of negative emotions.

  Baseline, immediately after the intervention

• Change cultural humility, as determined by the cross-cultural scale

  This adaptation of the Cross-Cultural Care Scale55 measures cultural humility preparedness and skills towards multiple identities. Intervention participants, relative to control participants, will have an increase in the mean of cultural humility.

  Baseline, immediately after the intervention

Secondary Outcomes (1)

• Sex as a biological variable

  Baseline, immediately after the intervention

Study Arms (2)

Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module

EXPERIMENTAL

Participants assigned to the experimental condition will receive the CC-TRAINED intervention.

Behavioral: Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module

Disaster Preparedness Course

OTHER

Participants randomized to the control condition will receive a Disaster Preparedness Course, addressing the basics of natural disaster preparedness

Behavioral: Disaster Preparedness Course

Interventions

Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module BEHAVIORAL

An online course designed to increase cervical cancer prevention clinical skills among medical students when working with Latinx transmasculine populations.

Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module

Disaster Preparedness Course BEHAVIORAL

An online course designed to improve professionals' skills and competencies for engaging in disaster preparedness.

Disaster Preparedness Course

Eligibility Criteria

• Age: 21 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Medical student currently in third year of medical school training

You may not qualify if:

• Do not speak English

Sponsors & Collaborators

• Ponce Medical School Foundation, Inc.: lead
• National Cancer Institute (NCI): collaborator
• H. Lee Moffitt Cancer Center and Research Institute: collaborator

Study Officials

• Alixida Ramos Pibernus, PhD

  Ponce Health Sciences University

  PRINCIPAL INVESTIGATOR

• Matthew B Schabath, PhD

  H. Lee Moffit Cancer Center and Research Institute

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Alixida Ramos-Pibernus, PhD

CONTACT

787-840-2575; aliramos@psm.edu

Matthew B Schabath, PhD

CONTACT

813-745-4150; matthew.schabath@moffitt.org

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 19, 2025
• First Posted: February 25, 2025
• Study Start: April 7, 2025
• Primary Completion (Estimated): August 31, 2026
• Study Completion (Estimated): August 31, 2026
• Last Updated: March 4, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share